• 1
    Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:24862497.
  • 2
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:7679.
  • 3
    Bonow RO, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med. 1996;101:17S22S.
  • 4
    Scognamiglio R, Negut C, Ramondo A, et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:65–71.
  • 5
    American Heart Association: Prevention Conference VI: diabetes and cardiovascular disease. Circulation. 2002;105:22312239.
  • 6
    Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes. J Am Coll Cardiol. 2005;45:5053.
  • 7
    Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction An update on the Framingham study. N Engl J Med. 1984;311(18):11441147.
  • 8
    Thaulow E, Erikssen J. Prognostic implications of asymptomatic cardiac ischemia. Cardiology. 1994;85:1115.
  • 9
    American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;21:15511559.
  • 10
    Klocke FJ, Baird MG, Bateman TM, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). Circulation. 2003;108:14041418.
  • 11
    De Lorenzo A, Lima RS, Siquiera-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computer tomography in asymptomatic patients with diabetes mellitus and no know coronary artery disease. Am J Cardiol. 2002;90(8):827832.
  • 12
    Giri S, Shal LJ, Murthy DR. Impact of diabetes on the risk stratification using single-photon emission computer tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105:3240.
  • 13
    Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care. 2004;27:19541961.
  • 14
    Young LH, Wackers FJ, Chyun DA, et al; for the DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA. 2009;301(15):15471555.
  • 15
    Rajagopalan N, Miller TD, Hodge DO, et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:4349.
  • 16
    Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:10471053.
  • 17
    Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229234.